Freder1k-Study - Testing Infants for Type 1 Diabetes Risk

NCT03316261 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000000

Last updated 2024-12-17

No results posted yet for this study

Summary

The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.

Conditions

  • Identification of Infants at Risk for Type 1 Diabetes

Sponsors & Collaborators

  • Helmholtz Zentrum München

    lead INDUSTRY

Principal Investigators

  • Anette-Gabriele Ziegler · Helmholtz Zentrum München, IDF-1

Eligibility

Min Age
1 Day
Max Age
6 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-19
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03316261 on ClinicalTrials.gov